Integration & Change: Transforming the Opioid Epidemic in Missouri

Resources (Click to download PowerPoints):

Dr. Rachel Winograd: “Missouri’s Response to the Opioid Crisis”

Dr. Angeline Stanislaus: “Medications for the Treatment of Opioid Use Disorders: Why Use Them and How They Work”

Nick Szubiak, MSW, LSCW: “The Opioid Epidemic: Opportunities for Creating New Systems of Care”

Percy Menzies: “Treating Addictive Disorders as ‘Internal’ Homelessness”

Dr. Mark Carlson: “Neurobiology of Addiction”

Dan Adams: “Changing the Culture: A Bio/Psycho/Social Model for Opioid Treatment”

Dr. Omar Manejwala: “The Future of Addiction” (external link to his own site)


October 11, 2018
9:00 am to 5:00 pm
University Plaza Convention Center – Springfield, MO

Lunch & Snacks Provided

Contact: Mandy with questions about the conference or to request specific accommodations.


Leaders from across Missouri should plan to join this state-wide conference. Whether you are a provider, administrator, policy maker, advocate, educator, community agency representative, law enforcement professional, public health official, or business representative this issue is relevant to you.


Omar Manejwala, M.D. – Senior Vice President & Chief Medical Officer
Los Angeles, California

Rachel P. Winograd, Ph.D. – Assistant Research Professor
Missouri Institute of Mental Health, University of Missouri-St Louis
St. Louis, MO

Angeline Stanislaus, M.D. – Chief Medical Director – Adult Services
Missouri Department of Mental Health
Jefferson City, MO

Percy Menzies, M. Pharm. – President
Assisted Recovery Centers of America, LLC
St. Louis, MO

Dan Adams, M.B.A – Director of Administrative & Support Services
Southeast Missouri Behavioral Health
Salem, MO

Mark L. Carlson, M.D. – Medical Director
Cox Center For Addictions
Cox Health Hospitals
Springfield, MO

Nick Szubiak, MSW, LCSW – Integrated Health Consultant
NSI Strategies
Washington, D.C.


Omar Manejwala, M.D.

Omar Manejwala, M.D. is board certified in Psychiatry and Addiction Medicine. He currently serves as Chief Medical Officer at Catasys, a health services management company. Dr. Manejwala previously served as Medical Director at Hazelden foundation. After receiving his medical degree from University of Maryland School of Medicine, he completed his residency in Psychiatry at Duke where he served as Executive Chief Resident. He obtained his M.B.A. from the University of Virginia’s Darden School of Business.

Dr. Manejwala is one of the nation’s leading experts on addictions, cravings and behavior. He has appeared on several national media outlets including Good Morning America, 20/20, ABC World News Tonight with Diane Sawyer, The CBS Early Show, The CBS Evening News with Katie Couric, and ABC News Primetime. He is the author of Craving: Why We Can’t Seem to Get Enough (Hazelden Publishing 2013) which explains why we crave and prescribes a practical approach to taming cravings of all sorts.

Angeline Stanislaus, M.D.

Dr. Stanislaus is currently the Chief Medical Director- Adult Services in the Missouri Department of Mental Health. She plays a key role in the implementation of a statewide program through the State Targeted Response (STR) Grant aimed at prevention and treatment of Opioid Use Disorders. She has worked closely with other experts in Missouri, developing the treatment guidelines for Opioid Use Disorders. She is part of the Opioid Crisis Management Team, which provides trainings to substance use treatment professionals across the state, consults with independent agencies in implementing empirically proven treatment for Opioid Use Disorders, identifies gaps in care, and implements effective strategies to bridge the gap.

Rachel P. Winograd, Ph.D.

Rachel Winograd, PhD, is a Research Assistant Professor at the Missouri Institute of Mental Health (MIMH) – University of Missouri St. Louis (UMSL). Her clinical, research, and program development interests have revolved around alcohol and drug use, consequences, and treatment. Dr. Winograd is the Project Director of Missouri’s State Targeted Response to the Opioid Crisis Grant and the MIMH Principal Investigator of the Missouri Heroin-Opioid Prevention and Education (MO-HOPE) Project. Her primary focus is on expanding access to medication assisted treatment and harm reduction strategies for those most in need of evidence-based care for opioid use disorders in Missouri.

Percy Menzies, M. Pharm.

Percy Menzies is the President of Assisted Recovery Centers of America, LLC, an outpatient center for the treatment of alcoholism and drug addiction based in St. Louis, Missouri. He holds a Masters in Pharmacy from India and immigrated to the United States in 1977. ARCA’s clinics treat in excess of 1500 patients a month through an integrated medical approach combining anti-craving medications with behavioral therapies. Under his leadership, ARCA has standardized the treatment of addictive disorders and developed strategies to reduce rates of recidivism by offering the bulk of the treatment in patient’s ‘home’ environment which is often filled with cues and triggers of past drugs or alcohol. Mr. Menzies has served on various state and federal committees to develop policies and guidelines for the treatment of opioid addiction and alcoholism. He has conducted workshops in the US and abroad on advances in the treatment of addictive disorders.

Dan Adams, M.B.A.

Dan Adams is Director of Administrative and Support Services for Southeast Missouri Behavioral Health. He oversees the operation of three crisis stabilization residential programs and fourteen community-based outpatient offices in southern Missouri. He was part of the first Missouri cohort to be trained as medication assisted recovery specialists (MARS). In 2010 SEMO-BH began providing medications to assist with SUD treatment, implementing a network of telehealth service providers to areas of Missouri without any access to buprenorphine waivered prescribers.  In 2014 SEMO-BH was tapped to participate in SAMHSA’s MAT-PDOA grant. Following the first year Mr. Adams attended and presented on the success of the grant in Missouri. After the introduction of State Targeted Response (STR) to the opioid crisis, agencies from throughout Missouri have visited SEMO-BH to view its medication first program at the request of the Missouri Division of Behavioral Health. Mr. Adams has participated in presentations at MIMH’s Spring Institute, MACA conferences, as well as state and national webinars on medication first treatment.

Mark L. Carlson, M.D.

Dr. Mark Carlson serves as the Medical Director for CoxHealth Center for Addictions. Dr. Carlson is certified as an addictionologist by the American Society of Addiction Medicine and is also board certified in Preventative Medicine. He holds an MD from the University of Nebraska Medical Center as well as a Master of Public Health degree from the University of California – Berkeley. In addition to his extensive experience in the field of addiction medicine Dr. Carlson has also been involved in medical research, occupational medicine and previously served as a Medical Officer for the US Centers for Disease Control.  Dr. Carlson is passionate about the field of addiction medicine and enjoys teaching and learning.

Nick Szubiak, MSW, LCSW

Nick Szubiak brings more than 20 years of experience in direct service, administration and clinical experience. Nick is an Integrated Health Consultant and Principal of NSI Strategies where he provides support for healthcare environments with an emphasis on integrated care and MAT. As the Assistant Vice-President of Addiction and Recovery at the National Council for Behavioral Health, and as an Integrated Health Consultant, he provided technical assistance, consultation and training toward bi-directional integration of behavioral health and primary care, SBIRT, and substance use treatment such as medication assisted treatment (MAT).


9 a.m. – Welcome

9:15 a.m. – Introduction: Dr. Rachel Winograd, “Missouri’s Response to the Opioid Crisis: What We’re Doing and Why”

10 a.m. – Dr. Angeline Stanislaus, “Medications for Treatment of Opioid Use Disorders: Why Use Them, and How Do They Work?”

11 a.m. – Nick Szubiak, “The Opioid Epidemic: Opportunities for Creating New Systems of Care”

12 p.m. – Break/Lunch

12:30 – 2 p.m. – Case Studies

Percy Menzies, “Treating Addictive Disorders as ‘Internal’ Homelessness”

Dr. Mark Carlson, “Neurobiology of Addiction”

Dan Adams, “Changing the Culture: A Bio/Psycho/Social Model for Opioid Treatment”

2:15 – 3:30 p.m. – Keynote Speaker: Dr. Omar Manejwala, “The Future of Addiction”

3:30 p.m. – Closing Panel

4:30 – 5 p.m. – Optional social networking

The day also will include messages from Senators Roy Blunt and Claire McCaskill.

Continuing Education

Continuing Education Credits

Learning objectives 

  • Introduce opioid use disorder as a physiological approach
  • Define the scope of the opioid issue at national, state & local levels
  • Identify past, current & future treatment practices with an emphasis on a medication first treatment model
  • Outline next steps for future possibilities with integrated care models that mitigate opioid use and provide immediate access for treatment

6 CEU’s available from the American Psychological Association